Leaders in Commercial Data and Analytics: Driving Patient Outcomes

IntegriChain is a rapidly growing multi-national team of innovators, engineers, data scientists, and industry experts. We help Life Sciences manufacturers transform Payer, Patient, and Distribution data into actionable insights that help patients start therapy faster and stay on therapy longer.

IntegriChain is a leading life sciences commercial data and analytics company that helps patients start therapy faster and stay on therapy longer. Our mission is to help all stakeholders in pharmaceutical access save as many patient days of therapy as possible, focusing on the access challenges presented after the patient and provider commit to therapy.

More than 165 life science manufacturers—including all top-10 and other leading Big Pharma and mid-market manufacturers as well as emerging and pre-commercial manufacturers—rely on insights delivered from IntegriChain’s data, analytics, and managed services. These innovative manufacturers use ICyte-delivered insights to drive strategic decision-making and on-going business management across their payers, specialty pharmacies, patient services, and distribution channel partners.

IntegriChain is backed by Accel-KKR, a leading Silicon Valley technology private equity firm. We recently merged with daVIZta, a leading provider of revenue analytics software, including gross-to-net (GTN) automation and government pricing solutions, strengthening our best-in-class Payer solutions and growing our team of world-class data scientists, engineers, and industry experts to more than 220. IntegriChain is headquartered in Philadelphia, PA, with locations in Somerset, NJ, Ambler, PA, Atlanta, GA, and Pune, India. 

World-Class Life Sciences Innovators
Rely on the IntegriChain Team

For more than 10 years, the world’s leading Life Sciences innovators in pharmaceuticals, biopharma & specialty pharmaceuticals, generics, and medtech use IntegriChain solutions on a daily basis to ensure that patients have access to their products when they are needed and to minimize the chances that a patient foregoes therapy. Today IntegriChain is the trusted partner for all top-10 and 17 of the top-20 life science companies and more than 140 other suppliers, totaling $300 billion in annual US commerce.

We are passionate about our customers’ mission – improving the lives of patients – and view it as our own.